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Myocardial infarction (MI) affects more than 8 million people in the United States alone. Due to the
insufﬁcient regeneration capacity of the native myocardium, one widely studied approach is cardiac
tissue engineering, in which cells are delivered with or without biomaterials and/or regulatory factors to
fully regenerate the cardiac functions. Speciﬁcally, in vitro cardiac tissue engineering focuses on using
biomaterials as a reservoir for cells to attach, as well as a carrier of various regulatory factors such as
growth factors and peptides, providing high cell retention and a proper microenvironment for cells to
migrate, grow and differentiate within the scaffolds before implantation. Many studies have shown that
the full establishment of a functional cardiac tissue in vitro requires synergistic actions between the
seeded cells, the tissue culture condition, and the biochemical and biophysical environment provided by
the biomaterials-based scaffolds. Proper electrical stimulation and mechanical stretch during the in vitro
culture can induce the ordered orientation and differentiation of the seeded cells. On the other hand, the
various scaffolds biochemical and biophysical properties such as polymer composition, ligand concen-
tration, biodegradability, scaffold topography and mechanical properties can also have a signiﬁcant effect
on the cellular processes.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
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Cardiac diseases have become the leading cause of death
throughout the world. There are around 2.5 million people die
annually from severe cardiovascular diseases such as myocardialAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
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States alone [1]. MI, commonly known as heart attack, is usually
caused by the blood supply interruption due to a collection of lipids
and/or white blood cells on the walls of the arteries. After MI, CHF
may happen following inﬂammation, cardiomyocyte apoptosis,
formation of the ﬁbrous scars, and the stress burden increase of the
surrounding myocardium tissues [2].
Myocardium functions can't fully be restored after MI or other
serious cardiac diseases due to the insufﬁcient regeneration ca-
pacity of cardiomyocytes. In normal state, cardiomyocytes in
mammals or human beings can rarely divide. Even after an injury,
the remaining cardiomyocytes have limited capacity to initiate the
DNA synthesis and to re-enter the cell division cycles [3]. Thus one
of the most crucial issues to cure cardiac diseases is to deliver
proper types of cells to the infarcted locations and/or to induce the
transplanted cells to differentiate into fully functional
cardiomyocytes.
In order to reduce post-MI mortality, various surgical in-
terventions such as mechanical circulatory devices and drugs have
been developed in recent decades [4]. None of these methods,
however, can fully restore the patients' cardiac functions [4]. Stem-
cell therapy and cardiac tissue engineering have been thus studied
in the goal of better maintaining myocardium function. The stem-
cell therapy directly delivers cells into the infarcted myocardium.
Cells that have been already utilized include induced pluripotent
stem cells (iPSCs) [5], embryonic stem cells (ESCs) [6], mesen-
chymal stem cells (MSCs) [7], cardiosphere-derived cells (CDCs) [8],
skeletal myoblasts [9] and cardiac stem cells (CSCs) [10]. Studies
found that after the injection of bone marrow-derived cells, car-
diomyocytes were found in the infarcted area of the heart and the
cardiac function was partially improved [6], indicating that these
cells may be capable of migrating to the infarcted locations and
differentiating into cardiomyocytes or inducing the survived car-
diomyocytes from other positions to the heart failure area [11].
Nevertheless, this method is still limited by the insufﬁcient cell
retention, survival, engraftment and differentiation rates. The
leaking of cells during the delivery and apoptosis of the injected
cells in the harsh ischemic environments have been suggested as
possible reasons [12]. To better address these problems, cardiac
tissue engineering could be an alternative strategy.
In cardiac tissue engineering, biomaterials and/or regulatory
factors are combined together with the stem cells or car-
diomyocytes to closely mimic the natural myocardium to improve
the cell proliferation, migration and differentiation. Natural bio-
materials including collagen [13e15], ﬁbrin [12], matrigel [16], self-
assembling peptide [17], decellularized extracellular matrix [18,19],
and synthetic polymers such as poly(lactide-co-glycolide) (PLGA)
[20], polycaprolactone (PCL) [21,22], poly(glycerol-sebacate) (PGS)
[23,24] and polyurethane (PU) [25e27] are now widely used in
cardiac tissue engineering. These biomaterials should be biocom-
patible and biodegradable. Ideally, they should possess naturally
occurring cardiac-tissue-like nanoﬁbrous structures and aniso-
tropic mechanical properties, providing an instructive microenvi-
ronment for the cells to attach, grow, migrate and differentiate.
Some of these biomaterials can also be used to deliver protein, gene
or RNAs together with the cells. Studies have discovered that by
controlling the properties of the biomaterials such as the matrix
stiffness [28e30], morphology [31,32] or chemical properties [33],
cardiac differentiation of the delivered stem cells can be signiﬁ-
cantly improved.
In this critical review, cardiac tissue engineeringe especially the
cell encapsulated scaffold-based cardiac tissue engineeringe will
be introduced and discussed. Biochemical and biophysical proper-
ties of the biomaterials that have been applied to induce stem cell
fates, especially cell cardiac differentiation, as well as theiradvantages and limitations will be presented and discussed here.
2. Cell encapsulated scaffold-based cardiac tissue engineering
Cell encapsulated scaffold-based cardiac tissue engineering fo-
cuses on seeding cells on pre-formed 3D scaffolds and controlling
the cell survival, proliferation and differentiation processes by
precise adjustment of the various scaffold properties as well as the
in vitro culture conditions before implanting in vivo. Among the
various cell types used for cardiac tissue engineering, ESCs can
differentiate into any cell type present in the heart, thus having the
potential to fully regenerate the myocardium. However, there're
two obstacles when applying ESCs to cardiac tissue engineering e
immunological rejection response and ethic controversies [6]. In
order to solve the ethic problem, iPSCs are introduced based on the
fact that they can be obtained by treating differentiated cells such
as ﬁbroblasts with stemness-related genes without sacriﬁcing an
embryo [34,35]. These reprogrammed cells gained pluripotency
and have been found to be able to differentiate into functional
cardiomyocytes. MSCs are proper candidate for cardiac therapy
based on the fact that they are locally immunosuppressive [36] and
can secrete paracrine growth factors for better myocardium
regeneration at the same time [37]. On the other hand, CSCs can be
isolated from human myocardium and expanded in vitro, sug-
gesting the possibility of using autologous CSCs to minimum the
immune rejections. CDCs can also be used autogeneically. They are
isolated from the explant of exocardium biopsies [8] and have a
quite fast proliferation rate. Other advantages of using CDCs include
their high differentiation capability into cardiomyocytes both
in vitro and in vivo compared with MSCs [8,38].
The basic requirement for the generated cardiac tissue con-
structs is to possess similar anisotropic mechanical properties e
especially stiffness and ﬂexibility e to natural myocardium, contain
high densities of cells, and have enough thickness for clinical
application (around 1.5 cm for human myocardium). Ideally, the
implanted constructs should be able to integrate with the host
tissues, deliver the electrical and mechanical signals within the
matrix to the transplanted cells, pace synchronically with the sur-
rounding tissues and promote angiogenesis for long-term
improvement of the cardiac functions. The scaffold properties and
the in vitro culture process both play important roles in the pro-
duced tissue constructs. Fig. 1 presents an overview of the cell
encapsulated scaffold-based cardiac tissue engineering process.
2.1. Scaffold types
Scaffolds that have been applied in the ﬁeld of cardiac tissue
engineering can be divided into gel, foam and nanoﬁbrous forms.
The gel-form scaffolds can be easily bonded to the host tissues.
Because of their injectability, they can be delivered by catheters to
avoid large surgeries. The pre-formed foam and 3D nanoﬁber net-
works, on the other hand, can well mimic the structure of the
natural myocardium extracellular matrix by precise control of the
pore size, pore shape, ﬁber diameter and orientation.
Both natural-derived and synthetic gels can be used for cardiac
regeneration. Collagen, for instance, as one of themain components
in ECM of themyocardium as well as an essential structural support
and mechanical property provider of the myocardium, has attrac-
ted signiﬁcant attention as a matrix for cell delivery. While
employing the collagen gels, cardiomyocytes or stem cells were
seeded into the collagen solutions and tissue constructs were ob-
tained by a simple gelation process [39,40]. Studies showed that by
mixing the collagen gel with rat neonatal cardiomyocytes, the
contractility of the infarcted heart was gradually improved, and the
maximum beating force was found 18 days after implantation [41].
Fig. 1. An overview of cell encapsulated scaffold-based cardiac tissue engineering process: Cells are seeded into scaffolds made of natural-derived or synthetic polymers, and the
tissue constructs are then cultured in vitro under speciﬁc conditions to develop into mature tissues before implantation in vivo.
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membrane protein matrix, mixed with neonatal cardiomyocytes
and cultured in vitro for 12 days before implanted into the infarcted
hearts. Vascularization was observed within the tissue constructs
14 days after implantation. By four weeks, the heart wall thickness
was dramatically increased and the myocardial dilation was
signiﬁcantly attenuated.
Foam is another widely applied scaffold form for cardiac tissue
engineering. Large surface area and high porosity make them
excellent structures for the cells to attach, migrate and communi-
cate with each other. Furthermore, the interconnected pores also
offer spaces for capillary growth. Foams can be prepared by
biomaterial solution lyophilization [42], salt leaching [43] or
microfabrication techniques to create complex geometries [44]. In
order to induce the cell alignment, the foam scaffolds are usually
designed with ordered channels or accordion-like honeycombs
[44]. Interestingly, Engelmayr et al. found that the accordion-like
scaffolds based on PGS possessed anisotropic mechanical proper-
ties closely matching the native heart tissues, with controllable
elastic modulus by changing the polymer curing time. Moreover,
better cell alignment and contractility inducible by electric ﬁeld
were also observed. One major limitation of the foam scaffolds is
the difﬁculty to seed cells homogeneously within the 3-D scaffolds.
Despite of the interconnected pores, cells usually have limited
ability to migrate into the inner parts of the scaffolds due to the
limited diffusion length of the nutrients and oxygen. In addition, a
risk of residual chemicals may exist if harsh chemical conditions are
required to produce the porous structures [45].
Nanoﬁber networks have also been utilized for cardiac tissue
engineering because of their capacity of closely mimicking the
nanoscale structure (collagen ﬁbers within the myocardium are
aligned nanoﬁbers) and mechanical properties of natural myocar-
dium. The highly ordered nanoﬁbers can direct the cardiomyocytes
alignment and contribute to anisotropic mechanical properties as
desired. These scaffolds are usually fabricated by electrospinning, a
drawing method through which micro or nanoﬁbers are producedfrom polymer solutions with an electric ﬁeld charging between an
output needle and a collection area. By changing the polymer so-
lution concentration and output speed, electric voltage or mandrel
(collection part) velocity, one can control the many properties of
the scaffolds including ﬁber diameter, density and alignment [46].
The nanoﬁbrous networks have a large surface to volume ratio
which can contribute to higher permeability, better cell migration
and communication. However, it is always limited by the inho-
mogeneous distribution and limited culture depth of the seeded
cells. Guan et al. carried out a method to produce 3D nanoﬁbrous
polyurethane scaffolds seeded with MSCs via electrospray/elec-
trospinning approach [47]. Cells were successfully and homoge-
neously distributedwithin the full thickness of the scaffolds, and no
signiﬁcant difference in cell growth kinetics, cell morphology or
MSC multipotency was found when comparing the electrosprayed
MSCs with the non-electrosprayed ones. The fabricated scaffolds
possessed a similar nanoﬁbrous and anisotropic structure as well as
stress-strain response to native porcine myocardium. Furthermore,
3-D alignment of the seeded cells within the scaffolds was obtained
by stretching the constructs during the in vitro culture. Cardiac
differentiation of MSCs was also upregulated, indicating the po-
tential of aligned ﬁbrous scaffolds for cardiac regeneration.2.2. Biomaterial-properties guided cardiac differentiation of stem
cells
When using biomaterials to build up a native-like microenvi-
ronment for the seeded cells, both the chemical and physical
properties of the biomaterial-based matrices/scaffolds are crucial
for cell proliferation, differentiation and integration with the sur-
viving myocardium tissues in damaged areas (Fig. 2). The physical
features of scaffolds that could moderate stem cells fate include the
various mechanical properties [28,48] and scaffold morphology
[49]. Additionally, the chemical properties of the applied bio-
materials such as the ligand composition [50], special ligand con-
centration [51] and matrix biodegradability [52,53] can also affect
Fig. 2. Biochemical and biophysical microenvironment properties that affect the fate of transplanted stem cells [54].
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Decades ago, ECMwas thought to be a passive component of the
myocardium and only act as a support for the cells. However,
studies have shown that the ECM patterns are changing in a speciﬁc
manner during the embryonic development, and its component
such as laminin, collagen or ﬁbronectin are expressed differently in
different stages [55]. Furthermore, the extracellular matrix me-
chanical properties were found to signiﬁcantly affect the stem cell
fates. Engler et al., for example, found that MSCs committed to the
lineages speciﬁed by matrix elasticity instead of other factors after
several weeks' culture in vitro. Soft matrices made of collagen-
coated polyacrylamide that mimic brain's elasticity are neuro-
genic, stiffer gels with similar modulus as muscles are myogenic
and relatively rigid matrices that mimic collagenous bones are
osteogenic (Fig. 3) [28].
Li et al. synthesized mechanically native-like thermosensitive
hydrogels and successfully induced the cardiac differentiation of
human mesenchymal stem cells (hMSCs) in vitro [56]. No signiﬁ-
cant difference in water content and oxygen permeability was
found between these hydrogels with different moduli (16 kPa,
45 kPa, 65 kPa). All hMSCs survived during a 2-week in vitro culture
period. Furthermore, 76% of hMSCs capsulated in hydrogel with
higher modulus (65 kPa) expressedMYH6 and CTnI proteins, which
are essential for cardiomyocytes to contract and relax, indicating
the successful cardiac differentiation of MSCs into cardiomyocytes.
This modulus-induced method possessed a much higher cardiac
differentiation of hMSCs than traditional approaches such as co-
culture hMSCs with cardiomyocytes [57] or using 5-azacytidine
[58], demonstrating a feasibility of using matrix stiffness alone to
induce stem cell cardiac differentiation. In Li's another study, the
optimal hydrogel-collagen matrix modulus for CDCs cardiac dif-
ferentiation was found to be 31 kPa [59]. As for ESCs, Kraehenbuehl
et al. used PEG gels to induce their cardiac differentiation and found
the optimal modulus was less than 1 kPa [60]. These distinguishingresults may stem from the different natures of the cells and
different chemical structures of the biomaterials.
On the other hand, Jacot et al. found that the elastic modulus of
the Black Swiss mice epicardium underwent signiﬁcant change
from 12 ± 4 kPa as the embryonic value to 39 ± 7 kPa as the
neonatal value, indicating that the modulus change might be a
critical effect on the development of neonatal cardiomyocytes [61].
As a result, attempts have also been made to produce 3D matrix
that could change its stiffness with time. For instance, Young et al.
synthesized a hydrogel that stiffened from around 1 kPae8 kPa
over a period of 300 h by crosslinking thiolated-hyaluronic acid
(HA) hydrogel with poly (ethylene glycol) diacrylate (PEGDA) [62].
This method was aimed to mimic the modulus change process of
the native heart as the cells developed into mature adult car-
diomyocytes. An increase of 3-fold in mature cardiac speciﬁc
markers as well as around 60% more functional cardiac muscle ﬁ-
bers were observed for cells cultured within this dynamic gel
compared with those in static polyacrylamide hydrogels, indicating
the possibility of improving the cardiac regeneration by a precise
control of the matrix stiffness over time.
Recently, except for the matrix stiffness effect, scientists found
that other mechanical factors such as the material loss modulus
[63,64], relaxation rate [65] and the mechanical dosing [66] may
also play an important role on stem cell fate control. Chaudhuri
et al., for example, reported that faster MSCs spreading, prolifera-
tion and osteogenic differentiation were observed when they were
cultured within 3D hydrogels with rapid relaxing rate (relaxing
time of around 1 min), independently of the hydrogel's initial
stiffness (17 kPa), degradation rate or available cell-adhesion li-
gands [65]. In another study, Yang et al. investigated themechanical
dosing effect on the stem cell fates using photo-tunable PEG
hydrogels [66]. They found that an irreversible activation of YAP/
TAZ and RUNX2 (pre-osteogenic transcription factor) happened
when the cells were cultured on stiff hydrogel (E ~10 kPa) long
enough before transferred to soft hydrogel (E ~2 kPa). These results
highlighted not only the effect of scaffold mechanical properties on
Fig. 3. Matrix elasticity (A) and differentiation of seeded naive MSCs (B) [28].
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chanical history/dynamics. Possible reasons of these effects include
the local clustering of integrins, mediation of actomyosin contrac-
tility and nuclear localization of transcriptional factors. Researchers
have found that certain signaling pathways such as Rho and Rac
could be activated when the integrin clustering happened, which
then contributed to the change of transcriptional factor activity and
cell differentiation ultimately [65].
2.2.2. Scaffold morphology
Besides the inﬂuence of scaffold/matrix mechanical properties,
morphology also plays a signiﬁcant role in the myocardium
regeneration process. In natural myocardium, cell may encounter
various levels of topography from macro level such as the shape of
blood vessels to micro level includes the projections and structure
of other surrounding cells, and to nano level such as the collagen
banding and protein conformation. All of these topographies havepotential to inﬂuence cell behavior and functionalities. As
mentioned above, pre-formed scaffolds such as porous foams or
nanoﬁbrous networks are widely used for cardiac tissue engineer-
ing. For porous foams, the interconnected pores provide cells with
space to migrate and communicate as well as a supply of oxygen
and nutrients, thus having a signiﬁcant inﬂuence on the seeded cell
distribution, density, migration and differentiation. For example,
Wei et al. produced a porous genipin-based biological scaffold with
a porosity of 91.2± 1.3% and a pore size of 130.5 ± 25.3 mm [67].
Shortly after inserting MSC multilayers into the scaffolds, the cells
started to adhere to the scaffold to promote proliferation and
migration. The tissue construct was then implanted in vivo using a
rat myocardial infarctionmodel after 7 days culture in vitro. The left
ventricle cavity was beneﬁcially reduced and the original pores
were ﬁlled by cells with neo-connective tissue ﬁbrils and neo-
microvessles. Expressions of angiogenic cytokines (bFGF, vWF,
and PDGF-B), cardiac protective factors (IGF-1 and HGF) and cardiac
Fig. 4. Different cell cardiac differentiation extents, as indicated by protein expressions of CX43 (b,e) and CTnI (c,f) were observed in CDCs seeded in scaffolds with different ﬁber
densities, ﬁber orientations and mechanical properties (a, d) [31].
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MSCs.
As for the nanoﬁbrous scaffolds, morphologies such as the ﬁber
alignment and ﬁber diameter can also make a difference on stem
cells fates. Ordered features such as parallel linear ﬁbrous struc-
tures have been seen to be able to induce the cell actin cytoskeleton
and the cell-matrix focal adhesion direction via the contact guid-
ance phenomenon. Micro or nano ﬁbers, on the other hand, are
capable of regulating cell spreading, orientation, proliferation and
differentiations, resulting from the fact that cells grown on them
exhibit a higher cells aspect ratio and smaller projection than those
grown on smooth substrates [49]. A good example is that Xu et al.
successfully stimulated the cardiac differentiation of CDCs using an
electrospun hydrogel/polyurethane ﬁbrous scaffold as indicated in
Fig. 4 [31]. The fabricated scaffolds reached ﬁber alignments above
45% and possessed anisotropic native-matched mechanical prop-
erties (macroscopic scaffoldmodulus between 50 kPa and 400 kPa).
After 7 days' culture in vitro in spinner ﬂasks, cells exhibited sig-
niﬁcant increase in cardiac differentiation at both gene and protein
levels in constructs with relatively low scaffold modulus (50 kPa),
low ﬁber alignment (45%) and high ﬁber volume fraction (85%). In
another study, Sreerekha et al. developed a multiscale electrospun
scaffold by electrospinning ﬁbrin and poly(lactide-co-glycolide)
(PLGA) simultaneously [68]. The ﬁbrin nanoﬁbers diameter
ranged from 50 to 500 nm and the PLGA microﬁber diameter was
around 2e4 mm. Confocal images showed that this hierarchical
structure allowed the cell migration into the interior parts of the
scaffolds and promoted the uniform distribution of the seeded cells.
Concurrently, cardiac speciﬁc proteins (a-sarcomeric actinin,
troponin, tropomyosin, desmin, and ANP) were expressed in
around 80% of the cells after 14 days' culture in vitro.
For other morphologies within the scaffolds, Tay et al. found that
human MSCs could be controlled to differentiate into myocardial
lineage by seeding them into ﬁbronectin micropatterns on PLGA
subtracts [69]. Themicropatterns weremade of 20 mm-wide stripes
separated by 40 mm-wide grooves. Images showed that patterned
cells exhibited elongated nuclei and cytoskeleton along the stripes,which suggested the possibility that cells may explore the topog-
raphy cues and relay the information to nucleus to initiate a certain
cellular process [70]. One explanation for the effect of topography
on cells fate is that the various scaffold morphologies could inﬂu-
ence the available surface area for protein adsorption, which re-
stricts the ECM deposition and ﬁnally the number/shape of initial
cell focal adhesion sites [70], and the change of cell focal adhesion
sites could affect many cellular activities including cell attachment,
migration, growth and differentiation via the mediation of
signaling pathways.
2.2.3. Ligand composition and concentration
Cells receive much of the information in the form of biochemical
cues from their local extracellular microenvironment. Protein sig-
nals, for instance, can bind to integrins, a transmembrane receptor
that locates on the cell surface, and the associations between them
can dictate the cell attachment, spread, proliferation and differen-
tiate rates [71]. In cardiac tissue engineering, on top of the me-
chanical and structural support function, the chemical ligand of
biomaterials make it possible for the scaffolds to serve as a delivery
system of these biochemical regeneration cues to the infarcted
myocardium. The strategies used to carry biomolecules include
non-covalent immobilization (by electrostatic or hydrogen
bonding), physical encapsulation and covalent bonding to the
functional groups of the biomaterials. Growth factors such as he-
patocyte growth factor (HGF), vascular endothelial growth factor
(VEGF) [72], insulin-like growth factor 1 (IGF-1) [73], and trans-
forming growth factor b (TGF-b) [55,74] have already been found to
have cardio-protective and cardiac differentiation effects, thus are
capable of improving cardiac regeneration [75]. On the other hand,
focal adhesions between cells and the extracellular matrix can be
formed by bonding speciﬁc peptides such as the arginine-glycine-
aspartic acid (RGD) [50,76,77] onto the biomaterials to promote
cell-matrix interactions.
Padin-Iruegas et al. bonded biotinylated IGF-1, a cardiomyocyte
division and differentiation factor, to the self-assembling peptide
nanoﬁbers and injected the mixture into infarcted rat myocardium
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with IGF-1 bonded nanoﬁbers (NF-IGF-1) showed a higher cell
proliferation rate and lower cell death than control groups (CPCs-
only and NF-IGF-1 only). Additionally, CPCs in NF-IGF-1 group
showed 32% and 230% higher differentiation into cardiomyocytes
comparedwith CPCs-only and NF-IGF-1 only groups, respectively. A
good example of applying the RGD-bonded biomaterial in cardiac
tissue engineering was carried out by Tan's group [79]. RGD was
coupled with self-assembling peptide RADA16 in order to enhance
the marrow-derived cardiac stem cells (MCSCs) survival and dif-
ferentiation. The scaffold underwent spontaneous assembling into
well-ordered nanoﬁbers with a diameter of around 10 nm. The
results showed the RGD modiﬁed scaffold signiﬁcantly decreased
the MCSCs death in ischemic environment. 4 weeks after implan-
tation, most of the cells in the RGD modiﬁed scaffolds expressed
cardiac mature markers cTnI and CX-43, and integrated well with
host tissue in aligned cell morphologies.
In addition to the ligand composition, the overall adhesion
ligand concentration or bulk concentration is also of great impor-
tance. When seeding carcinoma stem cells on RGD-modiﬁed PEG-
based hydrogel, for example, Kraehenbuehl et al. found that soft
matrix with a modulus of 322 ± 64.2 Pa induced the initial cardiac
muscle commitment [60]. However, further cardiac differentiation
of the carcinoma stem cells was inﬂuenced by the linkage between
integrin and RGD ligand. 6-fold increase of myosin heavy chain
(MHC)-positive cells were obtained when the RGD was 100 mM as
compared with cells in suspension. Other studies showed that the
ligand bulk or spatial distribution is especially critical for protein
delivery with chemotactic properties: a certain chemotactic
gradient had to be developed to deliver these chemokines [80].
Fugetaxis, in which cells are repelled instead of attracted, may
happen with a steep chemotactic gradient [81].
In addition to the ligand bulk concentration, the ligand line
concentration, which can also be treated as local spacing, have been
found to effect stem cell fate in other tissue engineering. Mooney
et al., for examples, cultured MC3T3-E1 cells into RGD-modiﬁed
alginate-based hydrogel with different RGD ligand spacing and
successfully regulated osteoblast differentiation [51]. The prolifer-
ation rate of seeded cells was upregulated from 0.59 ± 0.08 to
0.73 ± 0.03 per day and the cell differentiation was dramatically
promoted, as seen by a 4-fold increase of the secretion rate of the
osteocalcin, a typical osteoblast differentiation marker in the late
stage, with a ligand spacing from 78 nm to 36 nm. This study
suggested the possibility of using proper ligand spacing based on
certain biomaterials to induce cells cardiac differentiation for
myocardium regeneration.
These experiments showed a great potential of the biomaterials,
especially synthetic biomaterials used in cardiac tissue engineering,
by taking use of their functional groups to bond biomolecules with
speciﬁc properties to control over the cellular processes, especially
the differentiation of transplanted cells within the scaffolds and
ﬁnally develop a much more native-like and full functional tissue
constructs for clinical use. One of the big challenges with this
method lies in the fact that the biochemical cues in vivo are so
complex that we are still quite far away from fully understanding it.
Furthermore delivery of proteins to a receptor that is already acti-
vated by the endogenous proteins may be detrimental [82]. Finally,
the factors should be targeted to speciﬁc cell types to avoid their
possible toxic inﬂuence on other cells.
2.2.4. Material biodegradability
Optimally, the biomaterials used for cardiac tissue engineering
should degrade in a controllable rate without causing toxicity. They
should last long enough to guide the integration of transplanted
cells with the host tissues, but not too long to inhibit the eventualcellecell physiological coupling in the myocardium [83]. Tradi-
tional methods that have been applied to control the polymer
degradation rate include varying cross-linking densities, molecular
weight and combination of polymers with different degradation
rates. While studying hMSCs in a covalently crosslinked hyaluronic
acid (HA) hydrogel system that allows cell-mediated degradation,
Khetan et al. found that cells exhibited high degree of spreading
and exerted high tractions to the surrounding matrix, which
contributed to a high cell differentiation [53]. Furthermore, after
introducing non-degradable crosslinks into the matrix, a switch of
hMSCs behavior and fatewas observed through the block of cellular
traction generation in a manner similar as direct pharamacological
inhibition of myosin activities. These results indicated that stem
cell fates within covalently crosslinked hydrogels may be depen-
dent on the cell capability to generate tractions through the
degradation of surrounding matrix to remodel focal adhesions and
assemble cytoskeletal structures. As for the in vivo study, Xu et al.
developed an biodegradable hydrogel based on thiolated collagen
and multiple acrylate containing oligo (acryloyl carbonate)-b-
poly(ethylene glycol)-b-oligo (acryloyl carbonate) copolymers and
tested it in vivo using a rat infarction model [84]. Complete
degradation of the hydrogel was discerned on day 3. In vivo results
demonstrated that BMSC-encapsulated gels signiﬁcantly reduced
the infarct size, increased heart wall thickness and the ejection
fraction 28 days after implantation. In another study, Fujimoto et al.
developed a degradable hydrogel with elastic modulus of around
20 kPa and a degradation rate of 2 months in vivo for the treatment
of MI [85]. The hydrogel was synthesized from N-isopropyl acryl-
amide (NIPAAm), acrylic acid (AAc) and hydroxyl ethyl
methacrylate-poly(tremethylene carbonate) (HEMAPTMC). After 8
weeks, tissue ingrowth was observed in the injected hydrogel. In
addition, left ventricular wall thickness and capillary density was
dramatically increased in hydrogel group compared with the con-
trol group where PBS-only was injected. (see Fig. 5).
2.3. In vitro culture of scaffolds
As mentioned previously, the in vitro culture condition
including the dynamic stretching, electrical stimulation and mass
transfer is also an important aspect of tissue construct production.
Bioreactors have been widely used to enhance the mass transfer
between the tissue construct and its surrounding environment as
well as to provide a controllable basic condition such as pH, tem-
perature, oxygen and nutrient contents for the tissue constructs.
In static state, oxygen and nutrients can only diffuse to a
thickness of around 100 mmwithin the constructs [43], which limits
the size/thickness of non-vascularized tissue constructs. As a result,
sophisticated bioreactors such as rotating, perfusion or spinner are
applied to increase the mass transport. These ﬂasks have been
showed to enable sufﬁcient oxygen and nutrient transports for
cardiac tissues [86,87]. However, the eddies generated by the tur-
bulent ﬂow in spinner ﬂasks may be destructive for the seeded cells
[88]. As for perfusion ﬂasks, shear stresses are present during the
perfusion process, which may lead to a ﬁnal cell function difference
[89]. Rotating ﬂasks offer a dynamic environment with low shear
stress and comparatively high mass transfer [90], but they cannot
produce the necessary tensile stress that would occur in vivo [91].
Thus approaches such as placing oxygen carriers within the con-
structs [92], biomolecules modiﬁcation [93] or pre-vascularization
of the system [94] have been carried out to better supply the ox-
ygen and nutrients for cells.
In native myocardium, the orderly pacing of electrical signals
and macroscopic contraction are of great importance in the tissue
organization and functionalization process. Radisic et al. found that
by applying a 1 Hz, 5 V/cm, 2 ms monophasic square electrical
Fig. 5. Use of biodegradable (a) hydrogels based on NIPAAm, AAc and HEMAPTMC for the treatment of MI. (b) Increased LV wall thickness and capillary density were observed 8
weeks after gel injection; (c) H&E staining; (d) Immunohistochemical staining (blue: nuclear, green: a-SMA). Both of the images indicated the inﬁltration of cells into the hydrogels
(black dots are the injected hydrogel area) [85].
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the synchronic contraction was signiﬁcantly increased by 7 times
after 8 days' culture in vitro [95]. This study also suggested that the
conductive and contractile properties of the tissue constructsmight
depend on the application time of the electrical initiation. If the
electric stimulation is applied too early, the electric signals may
inhibit cardiac protein accumulation and yield poor contractility. If
applied too late, they may no longer have contribution to the
functional assembly of the cells [96]. Studies have already found
that the electric pulses can cause the hyperpolarization and de-
polarization of the cell ends, inducing cells to align according to theTable 1
Experimental results of some cardiac tissue engineering studies.
Material
type
Scaffold type Biomolecules
used
Cell type Culture condition
Collagen Gel e e In vivo
Matrigel Gel e Mouse ESCs In vivo
RAD16-II
peptide
Self-assembling
nanoﬁbers
IGF-1 Mouse
cardiomyocytes
In vivo
Fibrin Gel e Mouse
myoblasts
In vivo
PGS Accordion-like
honeycomb
foam
e Neonatal rat
heart cells
Static in vitro culture
with electric pulse
PU Nanoﬁbers e Mouse MSCs In vitro culture with
constant stretch
Collagen Gel e Neonatal rats
heart cells
In vitro culture with
dynamic stretch befo
implantation
Collagen Gel RGD Mouse
cardiomyocytes
Static in vitro culture
S.V. ¼ stroke volume; W.S. ¼ infarct wall thickness; E.F. ¼ left ventricle ejection fractio
transplanted cells; C.A. ¼ cell alignment; C.V. ¼ cell viability.electrical ﬁeld and to promote the formation of gap junction [97].
The increased gap junctions, at the same time, allow the cells to
communicate with each other to transfer signals, which leads to a
better synchronized contraction.
Considering the fact that the natural heart undergoes mechan-
ical stretch while pumping blood, mechanical strains are also
applied during the in vitro cultivation. Zimmerman et al. produced
a neonatal rat cardiomyocyte-embedded tissue construct based on
collagen/matrigel matrix and cultured the tissue constructs in vitro
under a 110% uniaxial stretching at a frequency of 2 Hz [98]. Inter-
connected and oriented cardiac muscle bundles were observed andAnimal model Improvement in cardiac function Reference
Fischer rats S.V. [, W. S. [, E.F. [ [13]
Lewis rats W.S. [, F.S. [, no LV dilation [16]
Sprague
eDawley rats
Activate Akt, C. D. [, increase myocyte cross-
sectional area, decrease caspase-3 cleavage
[17]
Sprague
eDawley rats
Angiogenesis [, decrease infarct scar size [12]
e Native-like stiffness, electric ﬁeld induced cell
contractility, C.A. [
[44]
e Native-like structure and stress-strain response,
C.A. [, C.D. [
[100]
re
Wistar rats Undelayed electrical coupling, prevent LV
further dilution, W.S. [, F.S. [
[98]
e High coupling yields, C.V. [, C.D. [, high cell
contractility
[50]
n; F.S. ¼ fractional shortening; LV ¼ left ventricle; C.D. ¼ cardiac differentiation of
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similar to natural myocardium. What's more, the engineered car-
diac tissues showed non-delayed electrical coupling to the host
tissues and also signiﬁcantly prevented the chambers' further
dilation, improving the cardiac functions after MI.
3. Conclusions and perspective
Cardiac tissue engineering hasmade huge strides in the past few
decades to improve the potential methods available for patients
with severe cardiac diseases compared with traditional strategies.
Table 1 lists some of the experimental results in cardiac tissue
engineering during the past few years. Despite of the fact that cell
encapsulated scaffold-based cardiac tissue engineering has been
successfully demonstrated to be able to improve the myocardium
regeneration, and the various biophysical and biochemical cues
mentioned above have been intensively studied these years to
obtain a better control over the many cellular processes including
the cell attachment, migration, division and differentiation, there
are still some signiﬁcant issues associated with this strategy. First,
the tissue constructs cannot provide a native-like enough micro-
environment for the development of a full functional cardiac tissue.
Accordingly, biomaterials with matched mechanical properties
(cardiac muscles are highly ﬂexible and soft with elastic modulus
around 1e140 kPa and fracture strain around 100% [71]) and similar
ﬁbrous structure with proper spatial and local micro and nano-
topography distribution are in need.
In addition, the transplanted cells within the scaffolds usually
have limited engraft, growth and differentiation rates in the long
term due to the ischemic environment in the infarcted myocar-
dium, asking for the adequate angiogenesis within the scaffolds
in vitro and/or vivo. In order to stimulate angiogenesis, endothelial
cells, which are capable of forming blood vessels to provide oxygen
and nutrients as well as exerting tropic and inotropic effects on
cardiomyocytes [72], and various biomolecules such as stromal cell
derived factor 1(SDF-1) [99] and vascular endothelial growth factor
(VEGF) [6] were delivered by biomaterials. For instance, Segers et al.
locally delivered protease-resistant SDF-1 by tethering it to self-
assembling peptides and injected it into infarcted rat myocar-
dium [73]. Capillary density was increased from 169 ± 42 to
283 ± 27 per mm2, and cardiac function, especially the ejection
fraction, was increased signiﬁcantly compared with control group
in which native SDF-1 alone was delivered.
Finally, considering the large number of biomolecules that
participate in the cardiac regeneration process, it is a big challenge
to deliver all the signals at once. As a result, delivering key proteins
at the right time and place is of great importance. Recently, various
drug or proteins delivery or release systems including the pH-
responsive release and oxidative stress-sensitive release were car-
ried out based on the bioactivity and biodegradability of the applied
biomaterials. A crucial aspect for the success of these systems will
be the temporal orchestration as well as the direct correlations
between the disease stages, release kinetics and therapeutic effects.
With this in mind, a deep exploration of the stimuli change at
different stages and precise design of biomaterials capable of
detecting these changes with the corresponding sensing groups are
essential.
The successful reestablishment of a favorable extracellular
microenvironment for cardiac tissue regeneration asks for the
synergistic actions between seeded cells, biomaterials-based scaf-
folds and multiple biomolecules such as growth factor and RGD
peptide [75]. Despite of the problems listed above, signiﬁcant
progress on cell-seeded biomolecule-modiﬁed 3D scaffold appli-
cation in cardiac tissue engineering has been witnessed during the
past few decades. Additionally, researchers are gaining a better anddeeper understanding of the effects of various physical and
chemical cues such as scaffold matrix mechanical properties, micro
or nano topography, biomaterial composition, ligand concentration
and biodegradability on cell fates. Such an increasing understand-
ing of the cells' response to their microenvironment provides an
improved and encouraging insight for future studies into a more
rational and proper design of the scaffolds to better regenerate the
infarcted cardiac tissues.
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